心脑血管病的发病率与死亡率逐年上升,而高脂血症是该病发病的重要危险因素。我们应用降脂药物甘糖酯对高脂血症患者进行治疗,取得了一定的疗效。报道如下。 1 临床资料 选自门诊或住院的高脂血症患者,共60例,其中男性52例,女性8例,年龄49～71岁,平均62.4±1.2岁。近4周未用过任何降脂药物,除外任何肝胆疾病,肝肾功能损害,未控制好的糖尿病,甲状腺功能失常,胰腺炎或其它影响脂质代谢的疾病。根据WHO关于高脂蛋白分型,参考“血脂异常防治 The incidence of cardiovascular and cerebrovascular diseases and mortality increased year by year, and the incidence of hyperlipidemia is an important risk factor for the disease. We use the lipid-lowering drug glycolipid in patients with hyperlipidemia treatment, and achieved a certain effect. Reported as follows. 1 clinical data were selected from outpatients or hospitalized patients with hyperlipidemia, a total of 60 cases, of which 52 males and 8 females, aged 49 to 71 years, mean 62.4 ± 1.2 years. Nearly 4 weeks without any lipid-lowering drugs, except for any hepatobiliary disease, liver and kidney dysfunction, uncontrolled diabetes, thyroid dysfunction, pancreatitis or other diseases affecting lipid metabolism. According to the WHO classification of high-fat protein, refer to the "prevention and treatment of dyslipidemia